News
Law enforcement agencies from across Southern Oregon gathered Monday to honor Jackson County Sheriff’s Corrections Deputy Kenneth “KC” Merck, who died unexpectedly on June 17, 2025, following a sudden ...
Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat head and neck cancers. Studies found patients taking Keytruda can reduce ...
Merck MRK announced FDA approval for its prophylactic long-acting monoclonal antibody, clesrovimab, for the prevention of RSV in newborns and infants born during or entering their first RSV season ...
Merck & Co. won US approval for a shot that protects against RSV, the most common cause of hospitalization among infants. The Food and Drug Administration approved Merck’s preventative drug for ...
Mix DRUMS brings together a number of effects in a streamlined interface to help you craft impactful, professional-sounding drums. It's designed to be used across a variety of applications, from ...
Editor’s note: This story was updated at 8:47 a.m. June 19, 2025, to note that Merck Manuals – a separate entity from Merck – launched the new tool.
Citizens Financial Group (CFG) will be expanding its share buyback program to $1.5 billion. Pharmaceutical giant Merck (MRK) received approval from the US Food and Drug Administration (FDA) to use ...
FDA approval of Merck’s RSV antibody drug, Enflonsia, makes it a direct competitor to Sanofi’s Beyfortus. The new Merck product is expected to be discussed by the CDC’s Advisory Committee on ...
The FDA has blessed Merck’s Enflonsia to prevent RSV in infants. The shot will challenge Sanofi and AstraZeneca’s blockbuster Beyfortus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results